Navigation Links
Westminster Safety Disagreement Highlights Risk in Schools
Date:3/25/2009

LONDON, March 25 /PRNewswire/ -- Clinica - the world's leading medical technology journal - is calling for a public inquiry into the state of asbestos regulation in the UK, in light of discrepancies over the risk of exposure to asbestos at London's Palace of Westminster.

On the day of a parliamentary debate on the presence of asbestos in schools, the latest developments in Clinica's investigation into the extent of the problem and the ensuing healthcare need, add weight to calls for a more precautionary approach and greater readiness, including the creation of a national asbestos-related diseases research centre.

Clinica has obtained a report that updates and expands on allegations reported in June 2008. The report, produced for the Parliamentary Works Services Directorate by Goddard Consulting (an established asbestos safety consultant for the Palace authorities), dated January 23 2009, alleges that a series of recommendations have not been acted upon in relation to known and unknown levels of risk of exposure to asbestos in many parts of the Palace.

Prefacing the report with the warning that "the presence of asbestos has not been managed in accordance with the various regulations", the 112-page document summarises the location of known asbestos contamination; lists the "apparent breaches" to the Control of Asbestos Regulations 2002 and 2006, in the face of previous recommendations; and provides new recommendations based on the current situation. It also collates some 80 pages of survey reports and correspondence related to asbestos safety concerns, dating back to 2005.

In the light of the reassurances given to Clinica by both the Parliamentary Works Services Directorate (PWSD) and the Health and Safety Executive (responsible for regulating asbestos safety in the UK) since June 2008, the HSE was asked yesterday to confirm its position on asbestos safety at the Palace.

'/>"/>
SOURCE Clinica
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Palace of Westminster Asbestos Problem Ignored
2. As Breast Augmentation Becomes the No. 1 Cosmetic Surgery Procedure, New Jersey Plastic Surgeon Paul LoVerme, MD Discusses the Safety of Silicone Breast Implants
3. GAO Study Links Duty Circumvention with Evasion of Food Safety Laws
4. Research Validates Safety of Dawn AC Anticoagulation Management Software
5. Tips on Bicycling Safety From the American Academy of Orthopaedic Surgeons
6. Food Safety Expert Offers Tips to Be Safe in Wake of Costco & Safeway Egg Recall
7. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
8. Dr. Barry Friedberg comments on David vs. Goliath: Whos Really in the Pursuit of Patient Safety & Satisfaction?
9. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
10. Convection Cooled 150-Watt Open Frame Power Supply Meets Medical and Industrial Safety Standards
11. Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...he President of the American Academy of Disaster M... provides commentary and analysis from a disaster ...eak. Klein,s comments include: an explanation of ...ts are helping other health care providers; and wh...
...RAK International, Inc. (Nasdaq: DATA ), a techn...ical solutions for the clinical trials industry, t...GmbH (CPI), a German CRO, has become the newest me... (EDC) capabilities and empower its staff to more ...
...ol, statin medications have been found to have num...healthy man,s risk of developing advanced prostate... antigen (PSA) levels. , But a new study by resea...s PSA test and masking his risk for prostate cance...
...y and process management specialist is set to make...MidTech Partners, Inc., a member of the Microsoft ...il and the Microsoft BizTalk Virtual Technical Spe...th SOA, interoperability and business process serv...
...ectious Disease Expert Available to Comment on Swi...ORD, Conn., April 28 AmeriCares, a nonprofit hu...d infection control supplies to help several Texas...th flu symptoms while others are taking precaution...
...rs have made an important step forward in understa...trum disorders. A researcher collaboration, includ...a School of Medicine and The Children,s Hospital o...ppears to play a significant role in the genetic r...
Other Medicine News:Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 2Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 3Health News:American Academy of Disaster Medicine's (AADM) President Comments on U.S. Public Health System, Discusses Swine Flu Infection and Prevention 4Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 2Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 3Health News:German CRO clinicalprojects international GmbH Becomes Newest Member of DATATRAK's CRO Connect Program(TM) 4Health News:Statins alter prostate cancer patients' PSA levels 2Health News:MidTech Partners Ready for Microsoft BizTalk Server 2009 2Health News:Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 1FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 2Genital Herpes May Never Go Dormant 61659 1Genital Herpes May Never Go Dormant 61659 2Genital Herpes May Never Go Dormant 61659 3
...xpansion of Company,s Phase 3 Study for Wet AMD af...ata, FREMONT, Calif., April 17 NeoVista, Inc. an...ration (FDA) has granted the,company,s request to ...votal Phase 3 trial from 10 to 30 in the United St...ndary to AMD Treated with BEta RadiatioN,Epiretina...
...il 17 Innocoll, Inc., a privately-held,biopharmac...e planned phase,2 clinical trials sponsored by its...d, to investigate CollaRx(R) GENTAMICIN TOPICAL fo...c foot ulcers, has commenced,dosing. CollaRx GENTA...ble,Gentamicin-Collagen Sponge formulated and manu...
Other Medicine Technology:FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 4
Anis™ Suction Ring
Caro LASIK Flap Elevator
Fukasaku LASIK Spatula
Micro Knife, 30 Degree
Medicine Products: